|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Mar 11, 2021||advanced to third reading|
|Mar 10, 2021||2nd report cal.|
|Mar 09, 2021||1st report cal.541|
|Jan 19, 2021||referred to health|
senate Bill S2103
Current Bill Status - On Floor Calendar
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S2103 (ACTIVE) - Details
S2103 (ACTIVE) - Sponsor Memo
BILL NUMBER: S2103 SPONSOR: SEPULVEDA TITLE OF BILL: An act to amend the public health law, in relation to the use of psycho- tropic medications in nursing homes and adult care facilities PURPOSE OR GENERAL IDEA OF BILL: To require an enhanced level of informed consent before psychotropic medication can be prescribed for patients residing in nursing homes or adult care facilities. SUMMARY OF SPECIFIC PROVISIONS: Would add a new section 280-c to article 2-A of the Public Health Law to detail the information that must be provided before a health care professional may prescribe a psychotropic medication and require a writ- ten informed consent before the initial order, or before an increase in the dose or duration of an existing order. s.k 1 The bill accommodates
S2103 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 2103 2021-2022 Regular Sessions I N S E N A T E January 19, 2021 ___________ Introduced by Sen. SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to the use of psycho- tropic medications in nursing homes and adult care facilities THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 280-d to read as follows: § 280-D. USE OF PSYCHOTROPIC MEDICATIONS IN NURSING HOMES AND ADULT CARE FACILITIES. 1. AS USED IN THIS SECTION: (A) "PSYCHOTROPIC MEDICATION" MEANS A DRUG THAT AFFECTS BRAIN ACTIV- ITIES ASSOCIATED WITH MENTAL PROCESSES AND BEHAVIOR, INCLUDING, BUT NOT LIMITED TO, ANTIPSYCHOTICS, ANTIDEPRESSANTS, ANTIANXIETY DRUGS OR ANXIO- LYTICS, AND HYPNOTICS; (B) "LAWFUL REPRESENTATIVE" MEANS, WHERE A PATIENT LACKS CAPACITY TO CONSENT TO HEALTH CARE, A PERSON AUTHORIZED TO CONSENT ON BEHALF OF THE PATIENT, INCLUDING, BUT NOT LIMITED TO, A HEALTH CARE AGENT AUTHORIZED BY A HEALTH CARE PROXY UNDER ARTICLE TWENTY-NINE-C OF THIS CHAPTER OR A SURROGATE UNDER ARTICLE TWENTY-NINE-CC OF THIS CHAPTER; (C) "INCREASE" WHEN USED IN RELATION TO AN ORDER FOR A PSYCHOTROPIC MEDICATION, MEANS AN INCREASE OF THE DOSAGE OR DURATION OF THE MEDICA- TION ABOVE THE DOSAGE OR DURATION COVERED BY THE CURRENTLY ACTIVE CONSENT; (D) "HEALTH CARE PROFESSIONAL" MEANS A HEALTH CARE PROFESSIONAL, LICENSED, CERTIFIED OR AUTHORIZED TO PRACTICE UNDER TITLE EIGHT OF THE EDUCATION LAW, ACTING WITHIN HIS OR HER LAWFUL SCOPE OF PRACTICE, WHO HAS AUTHORITY TO ORDER A PSYCHOTROPIC MEDICATION; AND (E) "PATIENT" MEANS AN INDIVIDUAL WHO IS A RESIDENT OF A RESIDENTIAL HEALTH CARE FACILITY AS DEFINED IN ARTICLE TWENTY-EIGHT OF THIS CHAPTER, OR AN ADULT CARE FACILITY CERTIFIED UNDER SECTION FOUR HUNDRED SIXTY- ONE-B OF THE SOCIAL SERVICES LAW. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.